January 17, 2024
Introduction U.S. companies face unique challenges and opportunities in the global race to develop and market new pharmaceuticals. A critical step in this journey is navigating the European Medicines Agency’s (EMA) regulatory framework for Investigational Medicinal Product Dossier (IMPD) applications and Marketing Authorization Applications (MAAs). Understanding these processes is key […]
